array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Gsk Consumer Health, Inc." ["slug"]=> string(32) "4abba-us-gsk-consumer-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204" ["description"]=> string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company." ["address_street"]=> string(28) "184 Liberty Corner Rd Ste 78" ["address_place"]=> string(6) "Warren" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1994-02-28" ["website_domain"]=> string(7) "gsk.com" ["website_url"]=> string(19) "https://www.gsk.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(300) ["article_count"]=> int(452) } ["articles"]=> array(6) { [0]=> array(7) { ["title_en"]=> string(58) "Pfizer to sell partial stake in Haleon for more than £2bn" ["snippet_en"]=> string(135) "The pharmaceutical group plans to lower its holding in Haleon, which also makes Panadol painkillers and Nicorette gum, from 32% to 24%." ["url"]=> string(82) "https://whatsnew2day.com/pfizer-to-sell-partial-stake-in-haleon-for-more-than-2bn/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f703f8c0-3241-4452-b366-ead36ffd104c" ["source"]=> string(16) "whatsnew2day.com" ["publication_date"]=> string(10) "2024-03-18" ["categories"]=> array(5) { [0]=> string(13) "Collaboration" [1]=> string(18) "General Investment" [2]=> string(10) "Divestment" [3]=> string(11) "Acquisition" [4]=> string(12) "Stock Market" } } [1]=> array(7) { ["title_en"]=> string(103) "GSK earns 1,023 million with the sale of 2.9% of the share capital of Haleon, manufacturer of Sensodyne" ["snippet_en"]=> string(184) "The British pharmaceutical company GlaxoSmithKline (GSK) has earned 885.6 million pounds (1,023 million euros) from the sale of a package of 270 million Haleon shares, equivalent to..." ["url"]=> string(142) "https://www.pressdigital.es/articulo/economia/2023-10-06/4465969-gsk-ingresa-1023-millones-venta-29-capital-social-haleon-fabricante-sensodyne" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f5579800-6da8-420f-9b94-f16557b83d85" ["source"]=> string(15) "pressdigital.es" ["publication_date"]=> string(10) "2023-10-06" ["categories"]=> array(4) { [0]=> string(14) "Issuing Shares" [1]=> string(18) "General Investment" [2]=> string(19) "Investment Requests" [3]=> string(10) "Divestment" } } [2]=> array(7) { ["title_en"]=> string(118) "GSK earns 1,023 million with the sale of 2.9% of the share capital of Haleon, manufacturer of Sensodyne - Forbes Spain" ["snippet_en"]=> string(152) "The British pharmaceutical company GlaxoSmithKline (GSK) has earned 885.6 million pounds (1,023 million euros) with the sale of a package of 270 million" ["url"]=> string(139) "https://forbes.es/ultima-hora/347161/gsk-ingresa-1-023-millones-con-la-venta-de-un-29-del-capital-social-de-haleon-fabricante-de-sensodyne/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2277c941-5df1-4b3a-adc2-9222c12cdd86" ["source"]=> string(9) "forbes.es" ["publication_date"]=> string(10) "2023-10-06" ["categories"]=> array(3) { [0]=> string(18) "General Investment" [1]=> string(19) "Investment Requests" [2]=> string(10) "Divestment" } } [3]=> array(7) { ["title_en"]=> string(69) "Pfizer to exit GSK consumer health joint venture after London listing" ["snippet_en"]=> string(68) "US pharma group to sell down stake in Haleon business after July IPO" ["url"]=> string(63) "https://www.ft.com/content/85f28cd9-ca18-4f2b-8346-c22efdfe1382" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e34c335d-d226-4780-91d7-3c2c05e08aa6" ["source"]=> string(6) "ft.com" ["publication_date"]=> string(10) "2022-06-01" ["categories"]=> array(9) { [0]=> string(8) "Downtime" [1]=> string(20) "Business Development" [2]=> string(13) "Collaboration" [3]=> string(12) "Going Public" [4]=> string(18) "General Investment" [5]=> string(10) "Divestment" [6]=> string(11) "Acquisition" [7]=> string(12) "Stock Market" [8]=> string(25) "Business Model Resilience" } } [4]=> array(7) { ["title_en"]=> string(45) "GSK sells part of consumer products operation" ["snippet_en"]=> string(43) "Drug company looks to spin off other assets" ["url"]=> string(63) "https://www.ft.com/content/048829ee-2b34-11e1-9fd0-00144feabdc0" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c669928f-1eba-406b-8b94-62ca61970849" ["source"]=> string(6) "ft.com" ["publication_date"]=> string(10) "2011-12-20" ["categories"]=> array(3) { [0]=> string(8) "spin-off" [1]=> string(10) "Divestment" [2]=> string(17) "Consumer Behavior" } } [5]=> array(7) { ["title_en"]=> string(40) "Pfizer to Cut Stake in Haleon — Update" ["snippet_en"]=> string(98) "Pfizer plans to sell a stake in Haleon currently valued at around2 billion pounds($ 2.55 billion)," ["url"]=> string(92) "https://www.morningstar.com/news/dow-jones/202403181501/pfizer-to-cut-stake-in-haleon-update" ["image_url"]=> NULL ["source"]=> string(15) "morningstar.com" ["publication_date"]=> NULL ["categories"]=> array(3) { [0]=> string(11) "Acquisition" [1]=> string(10) "Divestment" [2]=> string(12) "Stock Market" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(28) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(27) } [2]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [3]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(21) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [5]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(18) } [6]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(17) } [7]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(17) } [8]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(15) } [9]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(14) } [10]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(14) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(13) } [12]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(12) } [13]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(11) } [14]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(10) } [15]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [16]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(8) } [19]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(6) } [22]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(6) } [23]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(6) "Crisis" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(6) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(6) } [28]=> array(2) { ["name"]=> string(24) "Employee Health & Safety" ["count"]=> int(6) } [29]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(5) } } } 4abba-us-gsk-consumer-health-inc